Answers are grounded in this paper and cite their sources.
Pediatric patients frequently present with illnesses strongly suggesting infection, but without a clearly identified etiology. Our center has recently added a commercially available plasma metagenomic sequencing assay to its available diagnostic testing. Our experience with the first 100 tests suggests that this technology has good clinical performance with >90% sensitivity.
No takes yet. Share an insight, caveat, or question.
Rossoff et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: